KRISTEN BECK: Open Payments
NPI 1023739075 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,058 in 50 payments from 14 companies in 2025. Trend: 2023 $851 · 2024 $776 · 2025 $1,058
Food & beverage: $1,058
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $342 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $157 |
| Medtronic, Inc. | 2 | $135 |
| Regeneron Healthcare Solutions, Inc. | 3 | $84 |
| Janssen Biotech, Inc. | 4 | $80 |
| Gilead Sciences, Inc. | 2 | $48 |
| Ipsen Biopharmaceuticals, Inc | 2 | $40 |
| PFIZER INC. | 2 | $38 |
| GENZYME CORPORATION | 2 | $35 |
| Ardelyx, Inc. | 2 | $33 |
Products named: RINVOQ, ENTYVIO, INTERSTIM, SKYRIZI, DUPIXENT, TREMFYA, IQIRVO, VELSIPITY.
Industry payments across GA — which companies pay providers there.
